WHY ARE THE RECOMMENDED METHOTREXATE DOSES NOT USED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: WHO IS GUILTY AND WHAT TO DO?

Научно-практическая ревматология

E. L. Nasonov¹  Yu. V. Muravyev² 

[1] V.A. Nasonova Research Institute of RheumatologyInstitute of Professional Education, I.M.Sechenov First Moscow State MedicalUniversity, Ministry of Health of Russia;V.A. Nasonova Research Institute of Rheumatology;

关键词: rheumatoid arthritis;    methotrexate;    randomized clinical trials;    biological agents;   

DOI  :  10.14412/1995-4484-2017-112-114

来源: DOAJ

【 摘 要 】

The paper discusses the use of the recommended methotrexate doses for the treatment of rheumatoid arthritis in the randomized clinical comparative trials with biological agents.

【 授权许可】

Unknown